Company profile · free preview
Ascentage Pharma Group International
AAPG · NASDAQ · Healthcare · Updated 11/18/2026
Five-year financials
| Fiscal year |
|---|
| Revenue |
| Net income |
| Diluted EPS |
| Operating cash flow |
| Free cash flow |
| Cash |
| Total debt |
Financials are being prepared.
Want the story behind these numbers? Ask Osiris anything about Ascentage Pharma Group International's filings — free.
Create free accountAscentage Pharma Group International return on capital (fiscal 2025)
ROIC
—
Return on capital
—
Return on equity
-156.5%
Return on assets
-37.8%
Gross margin
91.5%
Operating margin
-208.6%
Net debt / EBITDA
0.46x
SEC filings
No filings stored yet.
Ask anything about Ascentage Pharma Group International's filings
"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.
Start researching free